生命科学资讯

Aktis lands biotech's first IPO of 2026, raising $318M for radiopharmaceuticals

OpenAI brings ChatGPT to hospitals on the heels of launching consumer health tool

Sanofi calls rejection of potential MS blockbuster 'unexpected'

Illumina hires Eric Green as chief medical officer

Exclusive: Illumina hires former NHGRI director as chief medical officer - Endpoints News

Servier launches VC unit focused on European biotech startups

FDA staff cuts mostly didn't impact new drug review timelines, analysis finds

New Lilly data suggest Zepbound boosted effect of autoimmune drug

Secretive Rampart Bioscience closes after pursuing non-viral gene therapy

FDA rejects Vanda’s jet lag drug following yearslong dispute

HHS loses bid to suspend court block on 340B rebate pilot

Deregulating the rapidly evolving digital health industry

Charles River CEO Jim Foster to retire; Samsung Bio buys a GSK factory

Ollin’s drug clears retinal disease better than Roche’s Vabysmo in Phase 1b trial

Inside Doctronic's experiment to allow AI to refill prescriptions

French biotech Enodia gets €20.7M aided by Pfizer for protein degrader work

Charles Fuchs leaves Roche to steer ADC pipeline at Tubulis shortly after $401M Series C

Diagonal Therapeutics secures $125M in Series B co-led by Sanofi Ventures

Former Genentech leaders’ protein degrader startup EpiBiologics nets $107M

Lilly to pay $1.2B for Ventyx and its NLRP3 drugs